Skip to content

PHYTOS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHYTOS

BE 0876.812.296
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
-€17,024
2023 · -€23,393+€6,369
Equity
-€107,710
2023 · -€90,686-€17,024
Cash
€12,319
2023 · €76,913-€64,595
Balance sheet total
€70,666
2023 · €177,513-€106,847

Largest movements

2023 to 2024
Assets
  • Cash -€64,595

    down €64,595 (-84.0%), from €76,913 to €12,319

    mainly Other debts (-€60,019) and Tax, wage and social debts (-€17,906)

  • Tangible fixed assets -€39,370

    down €39,370 (-100.0%), from €39,370 to €0

  • Deferred charges and accrued income -€2,312

    down €2,312 (-98.5%), from €2,347 to €35

Equity and liabilities
  • Other debts -€60,019

    down €60,019 (-25.5%), from €235,033 to €175,014

  • Tax, wage and social debts -€17,906

    down €17,906 (-98.6%), from €18,155 to €249

  • Profit (loss) carried forward -€17,024

    down €17,024 (-10.9%), from -€156,823 to -€173,847

  • Trade debts -€11,813

    down €11,813 (-79.1%), from €14,926 to €3,113

Income statement
  • Depreciation -€13,828

    down €13,828 (-100.0%), from €13,828 to €0

  • Other operating charges +€5,509

    up €5,509 (+143.1%), from €3,851 to €9,360

  • Financial income -€2,148

    down €2,148 (-100.0%), from €2,148 to €0

  • Taxes -€147

    down €147 (-74.4%), from €198 to €51

  • Financial charges -€99

    down €99 (-25.8%), from €382 to €283

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 -€23,393
Gross operating margin -€48
Depreciation +€13,828
Other operating charges -€5,509
Financial income -€2,148
Financial charges +€99
Taxes +€147
Result 2024 -€17,024

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€103,880
Investment +€39,370
Financing -€85
Cash 2023 €76,913
Net result for the year -€17,024
Stocks and contracts +€1,439
Receivables within one year -€869
Deferred charges and accrued income +€2,312
Trade debts -€11,813
Tax, wage and social debts -€17,906
Other debts -€60,019
Investment in fixed assets (net) +€39,370
Short-term financial debts -€85
Cash 2024 €12,319
Every line side by side 45 lines
Line Code 2023 2024 Change %
Total assets 20/58 €177,513 €70,666 -€106,847 -60.2%
Fixed assets 21/28 €39,370 €0 -€39,370 -100.0%
Tangible fixed assets 22/27 €39,370 €0 -€39,370 -100.0%
Furniture and vehicles 24 €39,370 €0 -€39,370 -100.0%
Current assets 29/58 €138,143 €70,666 -€67,477 -48.8%
Stocks and contracts in progress 3 €1,439 €0 -€1,439 -100.0%
Stocks 30/36 €1,439 €0 -€1,439 -100.0%
Amounts receivable within one year 40/41 €57,033 €57,902 +€869 +1.5%
Trade receivables 40 €0 - =
Other amounts receivable 41 €57,033 €57,902 +€869 +1.5%
Current investments 50/53 €410 €410 = 0.0%
Cash at bank and in hand 54/58 €76,913 €12,319 -€64,595 -84.0%
Deferred charges and accrued income 490/1 €2,347 €35 -€2,312 -98.5%
Total equity and liabilities 10/49 €177,513 €70,666 -€106,847 -60.2%
Equity 10/15 -€90,686 -€107,710 -€17,024 -18.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €47,537 €47,537 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €45,677 €45,677 = 0.0%
Profit (loss) carried forward 14 -€156,823 -€173,847 -€17,024 -10.9%
Amounts payable 17/49 €268,200 €178,376 -€89,824 -33.5%
Amounts payable within one year 42/48 €268,200 €178,376 -€89,824 -33.5%
Financial debts 43 €85 €0 -€85 -100.0%
Credit institutions 430/8 €85 €0 -€85 -100.0%
Trade debts 44 €14,926 €3,113 -€11,813 -79.1%
Suppliers 440/4 €14,926 €3,113 -€11,813 -79.1%
Advances received on contracts in progress 46 €0 - =
Taxes, remuneration and social security 45 €18,155 €249 -€17,906 -98.6%
Taxes 450/3 €18,155 €249 -€17,906 -98.6%
Other amounts payable 47/48 €235,033 €175,014 -€60,019 -25.5%
Accrued charges and deferred income 492/3 €0 - =
Non-recurring operating income 76A €4,566 €1,703 -€2,863 -62.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,828 €0 -€13,828 -100.0%
Other operating charges 640/8 €3,851 €9,360 +€5,509 +143.1%
Gross operating margin 9900 -€7,282 -€7,330 -€48 -0.7%
Operating profit (loss) 9901 -€24,961 -€16,690 +€8,271 +33.1%
Financial income 75/76B €2,148 €0 -€2,148 -100.0%
Recurring financial income 75 €2,148 €0 -€2,148 -100.0%
Financial charges 65/66B €382 €283 -€99 -25.8%
Recurring financial charges 65 €382 €283 -€99 -25.8%
Profit (loss) for the period before taxes 9903 -€23,195 -€16,973 +€6,222 +26.8%
Income taxes 67/77 €198 €51 -€147 -74.4%
Profit (loss) for the period 9904 -€23,393 -€17,024 +€6,369 +27.2%
Profit (loss) for the period to be appropriated 9905 -€23,393 -€17,024 +€6,369 +27.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.